GlaxoSmithKline plc (GSK.L,GSK) reported a drop in first-quarter profit attributable to shareholders to 1.325 billion pounds from 1.525 billion pounds last year, with earnings per share falling to 26.3 pence from 29.6 pence a year ago.
However, core earnings per share for the recent quarter were 27.3 pence, higher than the prior-year quarter's 25.9 pence, up 7% in CER terms and 5% in sterling terms reflecting the strengthening of Sterling against the Euro and higher exchange losses on settled inter-company transactions, partly offset by the weakness of Sterling against the US Dollar and Japanese Yen.
Group turnover for the quarter went up 2% to 6.64 billion pounds from 6.585 billion pounds in the comparable period. In addition, the board has declared a first interim dividend of 17 pence per share. The company's 2012 outlook for sales growth and gradual expansion of core margin remained unchanged.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org